Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 374, Issue 4, 2007, Pages 305-309

  Ahn, Hye Sook ^a   Kim, Sung Eun ^a   Jang, Hyun Jong ^a   Kim, Myung Jun ^a   Rhie, Duck Joo ^a   Yoon, Shin Hee ^a   Jo, Yang Hyeok ^a   Kim, Myung Suk ^a   Sung, Ki Wug ^a   Kim, Seong Yun ^a   Hahn, Sang June ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Insulin sensitizer; Thiazolidinedione; Voltage gated K+ channel

Indexed keywords

POTASSIUM CHANNEL KV1.3; ROSIGLITAZONE; TROGLITAZONE;

AMPLITUDE MODULATION; ANIMAL CELL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; IC 50; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP;

ANIMALS; CHO CELLS; CHROMANS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; KV1.3 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; THIAZOLIDINEDIONES; VASODILATOR AGENTS;

EID: 33846221869     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0118-6     Document Type: Article

References (19)

1. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880-883
2. Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein R, Smith RG, Leibowitz MD (1996) Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137:4189-4195
3. Breum L, Bjerre U, Bak JF, Jacobsen S, Astrup A (1995) Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 44:1570-1576
4. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25:280-289
5. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1-6
6. Dal Ponte DB, Fogt DL, Jacob S, Henriksen EJ (1998) Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance. Metabolism 47:982-987
7. Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J (1997) Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc Res 35:341-350
8. Eto K, Ohya Y, Nakamura Y, Abe I, Fujishima M (2001) Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur J Pharmacol 423:1-7
9. Izumi T, Enomoto S, Hosiyama K, Sasahara K, Shibukawa A, Nakagawa T, Sugiyama Y (1996) Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach. J Pharmacol Exp Ther 277:1630-1641
10. Knock GA, Mishra SK, Aaronson PI (1999) Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes. Eur J Pharmacol 368:103-109
11. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956
12. 2+- dependent mechanism. Am J Physiol Cell Physiol 290:C345-C351
13. + channels in pancreatic beta-cells enhances glucose-dependent insulin secretion. J Biol Chem 277:44938-44945
14. + channels. Role in stimulus-secretion coupling. J Biol Chem 271:32241-32246
15. Snyders DJ, Yeola SW (1995) Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res 77:575-583
16. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, Snyders DJ (1996) Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94:562-570
17. Wagstaff AJ, Goa KL (2002) Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs 62:1805-1837
18. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM (1996) The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668
19. Xu J, Wang P, Li Y, Li G, Kaczmarek LK, Wu Y, Koni PA, Flavell RA, Desir GV (2004) The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci USA 101:3112-3117